GPT and metabolic syndrome: LSM was higher in patients with metabolic syndrome (5.47±2.01 vs 4.92±1.34 kPa in patients without metabolic syndrome; p = 0.062), in those with elevated ALT (6.54±2.80 vs 5.15±1.58 kPa; p = 0.032) and in those with GGT ≥ 30 IU/L (median value in patients with a valid Fibroscan; 5.69 ±1.77 vs 4.82±1.63 kPa; p = 0.0001).